Echocardiographic Evaluation in Asymptomatic Relatives of Patients with Dilated Cardiomyopathy Reveals Preclinical Disease

@article{Mahon2005EchocardiographicEI,
  title={Echocardiographic Evaluation in Asymptomatic Relatives of Patients with Dilated Cardiomyopathy Reveals Preclinical Disease},
  author={Niall Mahon and Ross T. Murphy and Calum A. Macrae and Alida L.P. Caforio and Perry M. Elliott and William J. McKenna},
  journal={Annals of Internal Medicine},
  year={2005},
  volume={143},
  pages={108-115}
}
Context Idiopathic dilated cardiomyopathy is familial in 25% of cases. However, identifying asymptomatic affected relatives is difficult because there is no specific molecular marker for the disease and penetrance of the genetic defect is incomplete. The natural history of asymptomatic disease is poorly defined. Contribution Clinical evaluation of asymptomatic relatives of patients with dilated cardiomyopathy showed that those with left ventricular enlargement or depressed fractional shortening… Expand
Guidelines for the diagnosis and management of familial dilated cardiomyopathy.
  • D. Fatkin
  • Medicine
  • Heart, lung & circulation
  • 2011
TLDR
Clinical screening with ECG and echocardiography of all first-degree relatives of index cases with "idiopathic" DCM is strongly recommended to identify familial disease and to determine the number of affected individuals within families. Expand
Prospective Familial Assessment in Dilated Cardiomyopathy: Cardiac Autoantibodies Predict Disease Development in Asymptomatic Relatives
TLDR
Among healthy relatives of DCM patients, AHAs are independent predictors of disease development within 5 years, and positive AHAs at baseline were independent predictor of progression. Expand
X-linked dilated cardiomyopathy: the important role of genetic tests and imaging in the early diagnosis and treatment.
TLDR
A case with an early diagnosis of an X-linked dilated cardiomyopathy guided by clinical features, cardiac MRI and genetic testing and the revealing of a potential endemic entity clustering in several male subjects of a community on Crete island is presented. Expand
Evaluation of Left Ventricular Enlargement as a Marker of Early Disease in Familial Dilated Cardiomyopathy
TLDR
Assessment of LV size and contractile function is required for differentiating between pathological and physiological causes of LVE and may help to identify those at risk of disease progression and can be a marker of preclinical cardiomyopathy. Expand
Current perspectives on the diagnosis and management of dilated cardiomyopathy Beyond heart failure: a Cardiomyopathy Clinic Doctor's point of view.
TLDR
Although significant progress has been achieved in the management of patients with dilated cardiomyopathy, it seems that the future treatments of this entity will be related to the specific pathological substrate. Expand
[Idiopathic dilated cardiomyopathy in children: Prognostic indicators].
TLDR
The most important negative markers affecting the length of survival of DCM patients were parental consanguinity, cardiomegaly detected on telecardiography, and a reduced EF level. Expand
Guidelines for the Diagnosis and Management of Familial Dilated Cardiomyopathy
TLDR
It is now recognised that approximately 25% of cases of “idiopathic” DCM have a positive family history, suggesting that an inherited gene defect might be the cause of the disorder (“familial DCM”), and a clinical presentation that is characterised by DCM alone is recognised. Expand
Current Pathophysiological and Genetic Aspects of Dilated Cardiomyopathy
TLDR
This chapter provides a review of dilated cardiomyopathy with specific focus on the pathophysiological aspects and genetic etiology of the disease. Expand
The Diagnosis and Evaluation of Dilated Cardiomyopathy.
TLDR
Assessment of myocardial fibrosis predicts both risk of sudden cardiac death and likelihood of LV functional recovery, and has significant potential to guide patient selection for cardioverter-defibrillator implantation. Expand
Inherited cardiac muscle disease: Dilated cardiomyopathy
TLDR
Genetic tests in probands and cascade family screening in clinically phenotyped families provide the basis for segregation studies that are major contributors to the assignment of a causative role of mutations in families. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 33 REFERENCES
Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease.
TLDR
Nearly one-third of asymptomatic relatives (29%) have echocardiographic abnormalities, and 27% of such relatives progress to development of overt DCM, and early identification of such people would permit appropriate intervention that might influence the serious complications and mortality of this disease. Expand
The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy.
TLDR
Dilated cardiomyopathy was found to be familial in at least one in five of the patients in this study, a considerably higher percentage than in previous reports. Expand
Familial dilated cardiomyopathy in the United Kingdom.
TLDR
Segregation analysis suggests that familial dilated cardiomyopathy is the result of the transmission of a rare autosomal dominant gene. Expand
Familial dilated cardiomyopathy.
TLDR
Familial dilated cardiomyopathy is frequent, cannot be predicted on a clinical or morphologic basis and requires family screening for identification, and initial molecular genetic data indicate that multiple genes and pathogenetic mechanisms can lead to FDC. Expand
Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group.
TLDR
Familial dilated cardiomyopathy is frequent, cannot be predicted on a clinical or morphologic basis and requires family screening for identification, and initial molecular genetic data indicate that multiple genes and pathogenetic mechanisms can lead to FDC. Expand
Desmin mutation responsible for idiopathic dilated cardiomyopathy.
TLDR
A novel missense mutation of desmin, Ile451Met, was identified as the genetic cause of idiopathic dilated cardiomyopathy, the first mutation detected in the desmin tail domain, and it suggests that the tail of Desmin plays an important functional role in cardiac tissue. Expand
Evidence from family studies for autoimmunity in dilated cardiomyopathy
TLDR
Presence of cardiac-specific autoantibodies in symptom-free DCM relatives provides evidence of autoimmunity in a subset of patients (58%), including familial and non-familial forms of DCM. Expand
Novel Cardiac Troponin T Mutation as a Cause of Familial Dilated Cardiomyopathy
TLDR
A novel missense mutation in the cardiac troponin T gene is identified by direct sequencing and confirmed by endonuclease restriction analysis in a large family with FDCM and appears that the phenotype, whether it be hypertrophy or dilatation, is determined by the specific mutation rather than the gene. Expand
The clinical course of idiopathic dilated cardiomyopathy. A population-based study.
TLDR
These population-based data challenge the clinical perception of the clinical course of idiopathic dilated cardiomyopathy based on referral practice prognostic studies and suggest that theclinical course of this condition may be more favorable than previously recognized. Expand
Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy.
TLDR
Although the overall prevalence of dystrophin defects in consecutive DCM male series is low, immunohistochemical and molecular studies are essential to identify protein and gene defects; screening studies are justified to define prevalence, clinical profile and genotype-phenotype correlation. Expand
...
1
2
3
4
...